Related Experiment Videos
[Intrauterine rhesus diagnosis]
1Frauenklinik Biel, Schweiz.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|January 1, 1989
Summary
Rh immune globulin prophylaxis faces challenges. Advances in fetal blood typing, anemia assessment via cordocentesis, and timely intervention before hydrops fetalis improve Rh-immunized pregnancy outcomes.
Area of Science:
- Maternal-fetal medicine
- Immunology
- Genetics
Context:
- Rh immune globulin administration recommendations have expanded.
- Persistent challenges remain in Rh prophylaxis for certain reproductive events.
- Rh immunization in pregnancy poses significant risks to fetal well-being.
Purpose:
- To review recent advancements in managing Rh-immunized pregnancies.
- To highlight improved diagnostic and therapeutic strategies.
- To emphasize the importance of early and accurate fetal assessment.
Summary:
- First-trimester fetal blood group determination via chorionic villus sampling is now possible.
- Invasive procedures like cordocentesis are crucial for assessing fetal anemia severity when maternal antibodies exceed 1:8.
- Liley method for amniotic fluid interpretation remains relevant for third-trimester assessment.
- Ultrasonography aids invasive procedures but cannot reliably differentiate mild from severe fetal disease.
- Therapy, including transfusions via cordocentesis, should commence before fetal hydrops develops (Hb < 5 g%).
Impact:
- These advances contribute to improved survival rates, exceeding 90% in reported cases.
- Enhanced diagnostic accuracy allows for more targeted and timely therapeutic interventions.
- Better management of Rh-immunized pregnancies can reduce fetal morbidity and mortality.